These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1250 related items for PubMed ID: 20057319

  • 1. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY, Lee JM, Shin CI, Lee DH, Moon SK, Kim KW, Han JK, Choi BI.
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [Abstract] [Full Text] [Related]

  • 2. Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas.
    Yoon JH, Lee EJ, Cha SS, Han SS, Choi SJ, Juhn JR, Kim MH, Lee YJ, Park SJ.
    J Vasc Interv Radiol; 2010 Mar; 21(3):348-56. PubMed ID: 20116285
    [Abstract] [Full Text] [Related]

  • 3. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Muhi A, Araki T.
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [Abstract] [Full Text] [Related]

  • 4. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH, Kim SH, Park MJ, Park CK, Rhim H.
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [Abstract] [Full Text] [Related]

  • 5. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ, Lee JM, Lee JY, Kim SH, Kim SJ, Han JK, Choi BI.
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [Abstract] [Full Text] [Related]

  • 6. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ.
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [Abstract] [Full Text] [Related]

  • 7. Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging.
    Haradome H, Grazioli L, Tinti R, Morone M, Motosugi U, Sano K, Ichikawa T, Kwee TC, Colagrande S.
    J Magn Reson Imaging; 2011 Jul; 34(1):69-78. PubMed ID: 21598343
    [Abstract] [Full Text] [Related]

  • 8. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.
    Kim SH, Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, Choi D, Lee WJ, Lim HK.
    AJR Am J Roentgenol; 2009 Jun; 192(6):1675-81. PubMed ID: 19457834
    [Abstract] [Full Text] [Related]

  • 9. Dynamic enhancement pattern of HCC smaller than 3 cm in diameter on gadoxetic acid-enhanced MRI: comparison with multiphasic MDCT.
    Park VY, Choi JY, Chung YE, Kim H, Park MS, Lim JS, Kim KW, Kim MJ.
    Liver Int; 2014 Nov; 34(10):1593-602. PubMed ID: 24673802
    [Abstract] [Full Text] [Related]

  • 10. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.
    Suh YJ, Kim MJ, Choi JY, Park YN, Park MS, Kim KW.
    AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994
    [Abstract] [Full Text] [Related]

  • 11. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
    Park MJ, Kim YK, Lee MH, Lee JH.
    Acta Radiol; 2013 Mar 01; 54(2):127-36. PubMed ID: 23148300
    [Abstract] [Full Text] [Related]

  • 12. Hepatocellular carcinoma in patients with chronic liver disease: a comparison of gadoxetic acid-enhanced MRI and multiphasic MDCT.
    Baek CK, Choi JY, Kim KA, Park MS, Lim JS, Chung YE, Kim MJ, Kim KW.
    Clin Radiol; 2012 Feb 01; 67(2):148-56. PubMed ID: 21920517
    [Abstract] [Full Text] [Related]

  • 13. Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.
    Yu MH, Kim JH, Yoon JH, Kim HC, Chung JW, Han JK, Choi BI.
    Radiology; 2014 Jun 01; 271(3):748-60. PubMed ID: 24588677
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH, Lee JM, Baek JH, Shin CI, Han JK, Choi BI.
    Radiology; 2015 Jan 01; 274(1):149-60. PubMed ID: 25203131
    [Abstract] [Full Text] [Related]

  • 15. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.
    Kim AY, Kim YK, Lee MW, Park MJ, Hwang J, Lee MH, Lee JW.
    Acta Radiol; 2012 Oct 01; 53(8):830-8. PubMed ID: 22847903
    [Abstract] [Full Text] [Related]

  • 16. Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.
    Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE, Choi JY.
    Radiology; 2010 May 01; 255(2):459-66. PubMed ID: 20413759
    [Abstract] [Full Text] [Related]

  • 17. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS, Lee JH, Chung JJ, Kim JH, Kim KW.
    Acta Radiol; 2008 Sep 01; 49(7):735-43. PubMed ID: 18608015
    [Abstract] [Full Text] [Related]

  • 18. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ, Yan FH, Wang JH, Lin J, Ji Y.
    J Magn Reson Imaging; 2009 Feb 01; 29(2):341-9. PubMed ID: 19161186
    [Abstract] [Full Text] [Related]

  • 19. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis.
    Kim YK, Lee YH, Kwak HS, Kim CS, Han YM.
    Clin Imaging; 2008 Feb 01; 32(6):453-9. PubMed ID: 19006774
    [Abstract] [Full Text] [Related]

  • 20. Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial?
    Kim YK, Kim CS, Han YM, Lee YH.
    Clin Radiol; 2011 Jun 01; 66(6):489-96. PubMed ID: 21367403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.